Lazard Asset Management »

Esperion Therapeutics shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $125k 34k 3.70
2025-03-31 $63k 44k 1.44
2024-12-31 $27k 12k 2.19
2024-09-30 $20k 12k 1.62
2024-06-30 $25k 12k 2.14
2022-12-31 $909k 146k 6.23
2022-09-30 $559k 84k 6.69
2022-06-30 $206k 32k 6.36
2022-03-31 $261k 56k 4.63
2021-12-31 $181k 36k 4.99
2021-09-30 $2.0M 169k 12.05
2021-06-30 $571k 27k 21.15
2018-03-31 $875k 12k 72.28
2015-06-30 $118k 1.5k 81.38
2015-03-31 $2.4M 26k 92.59
2014-12-31 $8.0k 200 40.00